Differential effects of carvedilol on norepinephrine release in normoxic and ischemic heart

Journal of Cardiovascular Pharmacology

Volumn 36, Issue 1, 2000, Pages 96-100

  Kurz, Thomas ^a   Richardt, Doreen ^a   Gorge, Bettina ^a   Hartmann, Franz ^a   Tölg, Ralph ^a   Katus, Hugo A ^a   Richardt, Gert ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Carvedilol; Ischemia; Norepinephrine; Adrenoceptor antagonist

Indexed keywords

BETA ADRENERGIC RECEPTOR; BISOPROLOL; CARVEDILOL; METOPROLOL; NORADRENALIN; PINDOLOL;

ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR EFFECT; CONCENTRATION RESPONSE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; NEUROTRANSMISSION; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT;

EID: 0033919623     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200007000-00013     Document Type: Article

References (7)

1. Yusuf S, Petro R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985;27:335-71.
2. Cleland JGF, Bristow MR, Erdmann E, Remme WJ, Swedberg K, Waagstein F. Beta-blocking agents in heart failure. Eur Heart J 1996;17:1629-39.
3. Frishman WH. Carvedilol. N Engl J Med 1998;339:1759-65.
4. Lechat P, Packer M, Chalon S, Cucherat M, Arab T, Boissel J. Clinical effects of β-adrenergic blockade in chronic heart failure. Circulation 1998;98:1184-91.
5. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-55.
6. Waagstein F, Hjalmarson A, Varnauskas E, Wallentin I. Effect of chronic β-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 1975;37:1022-36.
7. CIBIS Investigators and Committees. A randomized trial of β-blockade in heart failure: the Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 1994;90:1765-73.